Stockscreener 앱 받기
0.5308
2.82%
-0.0154
시간 외 거래:
.53
-0.0008
-0.15%
BiomX Inc 주식(PHGE)의 최신 뉴스
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference | PHGE Stock News - GuruFocus
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference - GlobeNewswire
BiomX Inc. (AMEX:PHGE) Q1 2025 Earnings Call Transcript - MSN
HC Wainwright Issues Pessimistic Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price - Defense World
BiomX Inc. Earnings Call: Optimism and Progress - TipRanks
PHGE: HC Wainwright & Co. Maintains Buy Rating, Lowers Price Tar - GuruFocus
BiomX (PHGE) Price Target Reduced by Analyst Yet Buy Rating Maintained | PHGE Stock News - GuruFocus
BiomX Inc (PHGE) Q1 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience - Yahoo Finance
BiomX Inc. Reports Q1 2025 Progress and Financials - TipRanks
BiomX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
BiomX Inc. SEC 10-Q Report - TradingView
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates - TradingView
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates | PHGE Stock News - GuruFocus
BiomX Breakthrough: Phase 2 Trial Reveals 40% Superior Efficacy in Fighting Antibiotic-Resistant Infections - Stock Titan
BiomX (PHGE) to Release Quarterly Earnings on Thursday - Defense World
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025 - GlobeNewswire
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025 | PHGE Stock News - GuruFocus
BiomX Inc. to Host Conference Call for First Quarter 2025 Financial Results and Business Updates - Nasdaq
JPMorgan Chase & Co. Invests $314,000 in BiomX Inc. (NYSEMKT:PHGE) - Defense World
Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Decreases By 48.2% - Defense World
BiomX (PHGE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
HC Wainwright Reiterates “Buy” Rating for BiomX (NYSEMKT:PHGE) - Defense World
Q1 Earnings Estimate for BiomX Issued By HC Wainwright - Defense World
What is HC Wainwright’s Estimate for BiomX FY2025 Earnings? - Defense World
What is HC Wainwright’s Forecast for BiomX Q1 Earnings? - Defense World
HC Wainwright Issues Positive Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price - Defense World
Earnings call transcript: Biomx Q1 2025 sees potential breakthrough in phage therapy By Investing.com - Investing.com South Africa
Earnings call transcript: Biomx Q1 2025 sees potential breakthrough in phage therapy - Investing.com India
Biomx stock plunges to 52-week low, hits $0.48 - Investing.com
Biomx stock plunges to 52-week low, hits $0.48 By Investing.com - Investing.com India
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure - GlobeNewswire
BiomX stock target soars to $21 on Phase 2 trial success - Investing.com India
BiomX Announces Positive Phase 2 Trial Results - TipRanks
BiomX reports progress in diabetic ulcer treatment By Investing.com - Investing.com Australia
BiomX reports progress in diabetic ulcer treatment - Investing.com India
BiomX Announces Positive Topline Results From Phase 2 Trial Evaluating Bx211 For The Treatment Of Diabetic Foot Osteomyelitis (DFO) - MarketScreener
BiomX Announces Positive Topline Results from Phase 2 Trial - GlobeNewswire
Major Clinical Success: BiomX's New Drug Shows Promise in Preventing Diabetic Amputations - Stock Titan
Phage Therapy Market Know the Scope and Trends - openPR
BiomX (PHGE) Expected to Announce Earnings on Wednesday - Defense World
BiomX Inc Reports Q4 2024 EPS of -$2.56, Revenue at $0.00 Millio - GuruFocus
BiomX Inc. Secures $12 Million in Financing to Advance Clinical Trials for BX004 and BX211 - Nasdaq
BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates - GlobeNewswire
Earnings Scheduled For March 25, 2025 - Benzinga
1.52%
1.15%
자본화:
|
볼륨(24시간):